CLINICAL_TRIALS
trial_result
· 2026-01-07
Clinical Trial Update: ATI-450 vs Placebo in Participants With Moderate to Severe Hidradenitis Suppurativa (HS) [Phase 2]
Summary
A phase 2 trial comparing ATI-450 to placebo in moderate-to-severe hidradenitis suppurativa has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Aclaris Therapeutics, Inc. | Conditions: Hidradenitis Suppurativa | Phase 2 | Status: COMPLETED | Results posted: 2026-01-07